Project Grant R21DE034446

Award Date 7/1/25
Completion Date 6/30/27
Dollars Obligated $464K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund research to investigate how the fungus Candida albicans interacts with the bacterium Streptococcus mutans to promote the formation and virulence of cariogenic biofilms, a key driver of severe early childhood caries (S-ECC). The $460,885 award, running from March 2025 to February 2030, will support laboratory studies to...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $656,315 to Temple University to study the impact of cyclic strain on the pathogenesis of oral microbes, particularly Candida albicans and denture-related microbiota. The goal is to mechanistically understand how biomaterial cyclic strain, driven by chewing forces, can influence the virulence and dysbiosis of oral...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) in the amount of $473,632 to the University of Toledo on May 1, 2025. The purpose of this 3-year project is to investigate the role of megakaryocytes (MEGs) and their response to the cytokine interleukin-17 (IL-17) in oral mucosal immunity, particularly during oropharyngeal candidiasis caused by Candida albicans. The research aims to elucidate the...
This $314,000 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to gain insights into the evolution of fungal resistance in the oral environment of HIV-positive individuals. The research will leverage an existing patient dataset to: 1) use long-read sequencing to profile the fungal mycobiome in patient saliva and caries samples, and 2) perform longitudinal...
This $194,400 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will support research on the effects of adolescent alcohol use on the oral microbiome and brain. The awardee, the Medical University of South Carolina, will recruit 126 adolescents (ages 14-18) with varying levels of alcohol use to collect salivary samples to assess the oral microbiome, with a focus on the Lactobacillus...
This federal Project Grant award of $857,215, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research on how the fungal pathogen Candida albicans adapts to different infection sites within the human body. The primary research objectives are to investigate how the C. albicans GCN5 acetylation enzyme regulates the fungus's virulence and antifungal drug resistance in both oral mucosal...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $226,500 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Medical University of South Carolina. The grant, titled "CD38 Signaling in Aging-Associated Immune Responses Induced by Oral Pathogens," aims to define how oral pathogens affect aging-associated immune responses and determine if inhibition of the CD38 enzyme can alleviate inflammatory bone loss and...
This $431,750 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) supports research to decipher the mechanisms by which two proteins, AAFLP-1 and AADCUB, regulate the production of exopolysaccharide (PNAG) in the oral bacterium Aggregatibacter actinomycetemcomitans. The research aims to investigate how these two proteins, which are unique to A. actinomycetemcomitans, independently...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $163,411 Project Grant under the Oral Diseases and Disorders Research (CFDA 93.121) federal grant program to The Ohio State University. The grant supports research to understand the interactions between Streptococcus mutans, a primary driver of dental caries, and other commensal oral bacteria. The research aims to explicate the nutritional niches and carbohydrate utilization preferences of these microbes within oral...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $258,990 to The Children's Hospital Corporation (Boston Children's Hospital) to examine the role of the Candida albicans TOR1 kinase and its N-terminal heat repeats in enabling this fungal pathogen to withstand oxidative stress imposed by the host immune system. The research aims to define the interactions between TOR1 and its...

This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the CFDA program for Oral Diseases and Disorders Research (93.121), provides $463,530 to Tufts University School of Medicine to investigate the pathogenicity of alcohol-tolerant strains of the fungus Candida albicans in the oral cavity. The research aims to determine if alcohol-tolerant C. albicans strains exhibit increased virulence and damage when interacting with human oral epithelial cells, both with and without the presence of alcohol. Additionally, the project will utilize a mouse model of oral candidiasis to measure the ability of these alcohol-tolerant strains to cause disease. The award period is from July 1, 2025 to June 30, 2027. This research seeks to advance the scientific understanding of how environmental factors, such as alcohol consumption, may influence the virulence and pathogenicity of opportunistic oral pathogens.

Generated 7/15/25, 8:08 AM